- In December 2023, SCHOTT Pharma announced the expansion of its operations through a new production facility in Serbia. This strategic investment is aimed at scaling up manufacturing capacity to meet the rising global demand for parenteral packaging. The development is set to improve supply chain efficiency and strengthen SCHOTT's foothold in the market
- In 2023, Gerresheimer introduced Cyclic Olefin Polymer (COP) vials specifically developed for sensitive biologics such as mRNA-based drugs. This innovation enhances drug safety and packaging performance, supporting the growing need for advanced materials in parenteral packaging, especially for next-generation therapeutics
- In 2023, BD (Becton, Dickinson and Company) launched a prefilled flush syringe with an integrated disinfection unit, streamlining the drug administration process in clinical settings. The solution improves operational safety and efficiency, expanding the range of offerings in the parenteral packaging sector
- In 2022, Terumo Pharmaceutical Solutions (TPS) introduced a ready-to-fill polymer syringe tailored for high-volume biotech drugs. This development addresses specific industry challenges, offering a robust packaging solution for complex formulations, thereby strengthening TPS’s position in the biopharmaceutical packaging segment
- In 2021, SCHOTT AG began the construction of a second melting tank for pharmaceutical glass tubing. The expansion is designed to increase production capacity and cater to the rising demand for high-quality parenteral glass packaging, contributing to the company’s long-term growth strategy in the healthcare sector
